Announcements
- Finnish Hospital Orders Nexstim NBS System 5
- Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
- Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market
- Neurosurgery Customer from Germany Orders Nexstim NBS System 5
- Nexstim Plc Business Update Q1 2024
- Nexstim Oyj:n liiketoiminnan päivitys, tammi-maaliskuu 2024
- Nexstim Oyj: Johdon liiketoimet, Hildén
- Nexstim Plc: Managers’ Transactions, Hildén
- Nexstim Oyj: Johdon liiketoimet, Forss
- Nexstim Plc: Managers’ Transactions, Forss
More ▼
Key statistics
As of last trade, Nexstim Oyj (5NX:FRA) traded at 2.65, 36.60% above the 52 week low of 1.94 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.65 |
---|---|
High | 2.65 |
Low | 2.65 |
Bid | 2.63 |
Offer | 2.93 |
Previous close | 2.63 |
Average volume | 0.00 |
---|---|
Shares outstanding | 6.77m |
Free float | 3.46m |
P/E (TTM) | -- |
Market cap | 18.81m EUR |
EPS (TTM) | -0.1956 EUR |
Data delayed at least 15 minutes, as of Jun 04 2024 07:10 BST.
More ▼